Cilostazol: all 123 studies that test it
Page 1 of 2. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.
- Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 DiabetesRecruitingNCT07719894Phase 4
- Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke SurvivorsRecruitingNCT07588932Early Phase 1
- Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid HemorrhageRecruitingNCT07249853Phase 3
- Cilostazol in the Treatment of Nonalcoholic Fatty Liver DiseaseRecruitingNCT07238985Phase 1/2
- Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With CilostazolNot yet recruitingNCT07180472Phase 4
- Cilostazol for Prevention of Recurrent Stroke TrialNot yet recruitingNCT07174414Phase 3
- Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid HemorrhageNot yet recruitingNCT07144956Phase 3
- CiLostAzol for pReventIon of Recurrent sTroke in AfricaNot yet recruitingNCT06919835Phase 3
- The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery AtherosclerosisRecruitingNCT06757764Phase 4
- Cilostazol in Parkinson's DiseaseNot yet recruitingNCT06612593Phase 2
- Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIARecruitingNCT06591390Phase 3
- Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIARecruitingNCT06591377Phase 3
- Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIARecruitingNCT06591351Phase 3
- Ticagrelor Versus Cilostazol in Ischemic StrokeRecruitingNCT06561867Phase 3
- Cilostazol vs. Aspirin in Acute Non-cardioembolic Stroke With Cerebral mIcrobleedsRecruitingNCT06530537Phase 3
- Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological CancersRecruitingNCT06492070Phase 2
- Ticagrelor Versus Cilostazol in Large-vessel Ischemic StrokeRecruitingNCT06202755Phase 3
- Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIARecruitingNCT06196047Phase 3
- EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE)Not yet recruitingNCT06138834Phase 2
- Cilostazol and Methotrexate in Rheumatoid ArthritisRecruitingNCT05594680Phase 3
- Retina is a Marker for Cerebrovascular HeathRecruitingNCT04753970Phase 1/2
- Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)RecruitingNCT03109288Phase 1/2
- Cilostazol for HFpEFCompletedNCT05126836Phase 2Results posted
- LACunar Intervention (LACI-2) Trial-2CompletedNCT03451591Phase 2/3Results posted
- Cilostazol After Lower Extremity Arterial Revascularization TrialTerminatedNCT02374957Phase 4Results posted
- Cilostazol Augmentation Study in DementiaCompletedNCT01409564Phase 4Results posted
- Cilostazol 50 mg Tablets Under Fasting ConditionsCompletedNCT00839930Phase 1Results posted
- Cilostazol 100 mg Tablet Formulations Under Fasting ConditionsCompletedNCT00838630Phase 1Results posted
- Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial DopplerCompletedNCT00741286Phase 4Results posted
- Fasted Bioavailability Study of Cilostazol Tablets, 50mgCompletedNCT00685802Phase 1Results posted
- Fasted Bioavailability Study of Cilostazol Tablets, 100 mgCompletedNCT00684762Phase 1Results posted
- Overcome Biochemical Aspirin Resistance Through Cilostazol CombinationCompletedNCT00446641Phase 4Results posted
- Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)CompletedNCT00234065Phase 4Results posted
- Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis IICompletedNCT00130039Phase 4Results posted
- Assess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal® in Patients With Intermittent ClaudicationTerminatedNCT06886620Phase 3
- Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIAStatus unknownNCT06591299Phase 3
- Cilostazol and Aspirin in Stroke and TIACompletedNCT06522113Phase 4
- Antiplatelet Therapy in Chronic UrticariaActive, not recruitingNCT06268470Phase 2
- Clopidogrel Versus Cilostazol in Large-vessel Ischemic StrokeCompletedNCT06242145Phase 3
- Clopidogrel Versus Cilostazol in Ischemic StrokeCompletedNCT06242132Phase 3
- BE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy VolunteersCompletedNCT06167265Phase 1
- Impact of Cilostazol Versus Cilostazol and Selenium Combination on the Healing of Diabetic Foot Ulcer PatientsCompletedNCT06117436Phase 2/3
- The Effect of Cilostazol on Rheumatoid Arthritis PatientsCompletedNCT05671497Phase 2/3
- Hypersensitivity to Phosphodiesterase 3 Inhibition in Post-Traumatic HeadacheStatus unknownNCT05595993Not applicable
- BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy VolunteersCompletedNCT05466734Phase 1
- Efficacy of Cilostazol in Prevention of Peripheral NeuropathyCompletedNCT05298696Phase 1/2
- Bioequivalence Study of PMR Compared to Cilostazol IR Tablets in Healthy VolunteersTerminatedNCT05191862Phase 1
- The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With OsteoarthritisWithdrawnNCT04789837Phase 1/2
- Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver DiseaseWithdrawnNCT04761848Phase 1/2
- Cilostazol and Endothelial Progenitor CellStatus unknownNCT04407312Phase 4
- Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)TerminatedNCT04148105Phase 4
- The Phosphodiesterase-3 Inhibitor Cilostazol as an Adjunctive to Antidepressants in Patients With Major Depressive Disorder.CompletedNCT04069819Not applicable
- Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy VolunteersCompletedNCT03864666Phase 1
- Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male SubjectsCompletedNCT03629067Phase 1
- Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial AneurysmCompletedNCT03581409Phase 4
- Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 DiabetesCompletedNCT03248401Phase 4
- The Effect of Cilostazol Compared to Aspirin on Endothelial Function in Acute Cerebral Ischemia PatientsCompletedNCT03116269Phase 4
- Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?CompletedNCT02983214Phase 4
- Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM PatientsStatus unknownNCT02933788Phase 4
- Cilostazol Following Peripheral Endovascular ProceduresStatus unknownNCT02770274Phase 3
- Investigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRICompletedNCT02549898Not applicable
- A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID)CompletedNCT02491268Phase 2
- PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT StudyStatus unknownNCT02483169Phase 4
- Lacunar Intervention Trial 1 (LACI-1)CompletedNCT02481323Phase 2
- Cilostazol-Simvastatin Drug Interaction StudyStatus unknownNCT02431013Phase 1
- Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DMCompletedNCT02266030Phase 3
- Induction of Migraine Aura With CilostazolCompletedNCT02253004Early Phase 1
- Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in High Risk for Cardiovascular DiseaseCompletedNCT02194686Phase 4
- Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in Coronary Artery DiseaseStatus unknownNCT02174939Phase 4
- To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia SubjectCompletedNCT02098460Phase 4
- Safety and Efficacy Study of Cilostazol to Treat Vasospastic AnginaCompletedNCT02094469Phase 3
- A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic AnginaCompletedNCT02087007Phase 3
- Cilostazol Stroke Prevention Study for Antiplatelet CombinationCompletedNCT01995370Phase 4
- OPTImal Management of Antithrombotic Agents: OPTIMA-2 TrialCompletedNCT01955200Phase 4
- Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD)CompletedNCT01952756Phase 4
- Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel DiseaseStatus unknownNCT01932203Phase 4
- Cilostazol and Its Effects on Resumption of Meiosis in the Human OvaryCompletedNCT01915069Phase 2
- Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND)Status unknownNCT01872858Not applicable
- Pharmacodynamic Drug Interaction Between Cilostazol and StatinsCompletedNCT01870466Phase 1
- The Headache Inducing Effects of Cilostazol on Migraine PatientsCompletedNCT01841827Not applicable
- Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI PatientsCompletedNCT01779401Not applicable
- The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy VolunteersCompletedNCT01482117Not applicable
- Safety and Pharmacokinetic Comparison of Cilostazol SR and IR Formulations in Healthy Korean VolunteersCompletedNCT01455558Phase 1
- Effect of Cilostazol on the Pharmacokinetics of SimvastatinCompletedNCT01383395Phase 1
- A Study on the Effect of Cilostazol in Patients With Chronic TinnitusCompletedNCT01378650Not applicable
- Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI)TerminatedNCT01346865Phase 4
- Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney DiseaseCompletedNCT01328470Phase 4
- Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIseaseCompletedNCT01291641Phase 4
- A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic NephropathyCompletedNCT01252056Phase 4
- Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After Biolimus-eluting Stent ImplantationCompletedNCT01192724Phase 4
- The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)CompletedNCT01188824Phase 4
- Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and SafetyCompletedNCT01142284Phase 2
- Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent ImplantationCompletedNCT01094457Phase 4
- Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the PhilippinesCompletedNCT01076478Phase 4
- PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhageStatus unknownNCT01013532Phase 4
- Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 PolymorphismCompletedNCT01012193Phase 4
- Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary InterventionStatus unknownNCT00938522Phase 4
- Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 PolymorphismCompletedNCT00915733Phase 4
- Sufficient Treatment of Peripheral Intervention by CilostazolStatus unknownNCT00912756Phase 4
- Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) PolymorphismStatus unknownNCT00891670Phase 3